In one of the first examples of aptamer-mediated delivery, Chu et al. [31] realized that the anti-PSMA aptamer could be employed to deliver this toxic payload into prostate cancer cells that express PSMA. The gene discussed is FOLH1; the disease is Familial prostate cancer.